6SY2 | pdb_00006sy2

Structure of the BRK domain of the SWI/SNF chromatin remodelling complex subunit BRG1 reveals a potential role in protein-protein interactions

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	2 mM unlabelled BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 800
2	2D TOCSY	2 mM unlabelled BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 800
3	2D DQF-COSY	2 mM unlabelled BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 800
4	3D HNCACB	1 mM [U-99% 13C; U-99% 15N] BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 600
5	3D CBCA(CO)NH	1 mM [U-99% 13C; U-99% 15N] BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 600
11	3D HNCO	1 mM [U-99% 13C; U-99% 15N] BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 600
10	3D HNCACO	1 mM [U-99% 13C; U-99% 15N] BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 600
9	3D HBHA(CO)NH	1 mM [U-99% 13C; U-99% 15N] BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 600
8	2D 1H-15N HSQC	1 mM [U-99% 13C; U-99% 15N] BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 600
7	2D 1H-13C HSQC	1 mM [U-99% 13C; U-99% 15N] BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 600
6	2D 1H-13C HSQC aliphatic	1 mM [U-10% 13C] BRG1 BRK domain	90% H2O/10% D2O	140 mM	6.5	1 atm	293	Bruker AVANCE 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800
2	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
torsion angle dynamics		CNS

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (none)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
3	chemical shift assignment	ANSIG		Kraulis
4	processing	Azara		Boucher

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.